Member Info for surf1

Optimer binders have been successfully developed to a novel Alzheimer's disease biomarker

The novel Alzheimer's disease biomarker, a peptide 'T14'was discovered and is currently being further validated by Neuro-Bio, led by the eminent neuroscientist Baroness Susan Greenfield. Early detection of Alzheimer's disease is critical to allow interventions that could prevent the onset of devastating memory loss and confusion in these patients. Neuro-Bio is working in parallel to develop a complementary therapy that could stabilise disease progression in diagnosed patients, ideally at the presymptomatic stage.

⬆️200% on this news alone!!

https://www.proactiveinvestors.co.uk/companies/news/1017834/aptamer-surges-on-breakthrough-in-development-of-alzheimer-s-early-diagnosis-test-1017834.html

Firm Placing, Conditional Placing and Subscription to Raise £3.6 million at 1p!!

17th August

2500000 share purchase at these prices!!!

My personal opinion is that it’s in favour for new positions…. The rewards could be big at these prices

@SV

I think you need to delve deeper into more recent activity.. You might learn something.

Obviously you are interested?

Okay lol

Being held back by the flippers!! Will fly on completion… can’t be much longer..1.30!!!

Share Options

The Company intends to put in place new share option schemes and to award share options to retain and incentivise the Directors and employees. The number of share options granted will be up to 25 per cent. of the issued share capital as enlarged by the Fundraise. These options will vest subject to stretching performance targets as follows:

(a) 16 per cent. on announcement of FY24 audited results in line with expectations and the share price having remained at or above 4 times the Issue Price for at least 3 months;

(b) 24 per cent. on announcement of FY25 audited results in line with expectations and the share price having remained at or above 7 times the Issue Price for at least 3 months;

(c) 40 per cent. on announcement of FY26 audited results in line with expectations and the share price having remained at or above 10 times the Issue Price for at least 3 months;

(d) 10 per cent. on announcement of FY26 audited results in line with expectations and the share price having remained at or above 30 times the Issue Price for at least 3 months; and

(e) 10 per cent. on announcement of FY26 audited results in line with expectations and the share price having remained at or above 50 times the Issue Price for at least 3 months.

Hence the reason we can buy at these prices. Easily 4p+ before Santa arrives imo

As stated in the post below 👇

Will we break 13p this week I wonder?

Https://x.com/poolbegpharma/status/1718885445365358890?s=46

This has potential for a herd gathering anytime soon…

Https://x.com/heliumone1/status/1718886323988160960?s=46

@Cricket81

Mr Andrew Leach Is buying at these prices… it’s a good indication IMO

Bottom feeding…

Https://x.com/poolbegpharma/status/1717783185663152364?s=46

They are in a good financial situation and progressing in the right direction so the SP won’t be at these levels for much longer

Https://x.com/aptamergroup/status/1717455136446984370?s=46

Https://x.com/poolbegpharma/status/1717421811363692718?s=46

Looking good for Poolbeg

Https://x.com/poolbegpharma/status/1717058658583122395?s=46

Wouldn’t surprise me to see another RNS soon with more buyers

Https://x.com/aptamergroup/status/1716747015739027584?s=46